-
Product Insights
Kuwait Oil – New Strategic Gas Export Pipeline: North Kuwait to MAA – Al Ahmadi
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kuwait Oil - New Strategic Gas Export Pipeline: North Kuwait to MAA - Al Ahmadi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Company Profile
Mitsubishi Research Institute Inc – Company Profile
Mitsubishi Research Institute Inc (MRI) is a provider of research, consulting and information technology (IT) services. The company’s IT services include data processing services, operation and maintenance, information processing, outsourcing services, software development, and sales of system equipment. It serves public offices and government, private sector companies and financial institutions. The company also provides research and analysis, public policymaking and planning, consulting, and business support services. It serves social and public sector which includes national land development, transportation and traffic,...
Add to Basket -
Company Profile
Mid-America Apartment Communities Inc – Company Profile
Mid-America Apartment Communities Inc (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven support services. The company also offers services includes myMAA.com, Move with MAA, Service on Call, MAAConnect and SMAArt Savings. MAA also offers furnished service apartments. The company owns, operates, acquires and develops apartment communities located in Alabama, Florida, Maryland, Tennessee, North Carolina, Virginia and...
Add to Basket -
Product Insights
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood. Risk factors for CML include high-dose radiation, age, and gender. Symptoms include weakness, fatigue, night sweats, weight loss, fever, bone pain, an enlarged spleen, and pain or a sense of fullness in the belly. Treatment includes radiation therapy, blood cell transplantation, and chemotherapy. The CML pipeline drugs market research report provides...
-
Product Insights
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Acute lymphocytic leukemia (ALL) is a cancer of the white blood cells due to the production of a large number of immature lymphocytes thus blocking the production of normal blood cells. Risk factors for ALL include exposure to radiation or chemicals, age, virus infections, and genetic factors. Symptoms include anemia, frequent infections, easy bruising, bone pain, and breathing problems. Treatment includes chemotherapy, transfusions, transplant, and medications. The ALL pipeline drugs market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Amyotrophic Lateral Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of amyotrophic lateral sclerosis include difficulty breathing, difficulty swallowing, head drop due to weakness of the neck muscles, muscle cramps, speech problems, such as a slow or abnormal speech pattern (slurring of words), voice changes, hoarseness, weight loss. The Amyotrophic Lateral Sclerosis pipeline market research report provides comprehensive information on the therapeutics under development for Amyotrophic Lateral Sclerosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type....
-
Product Insights
Actinic (Solar) Keratosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Actinic Keratosis Pipeline Drugs Market Overview An actinic keratosis, also known as solar keratosis, is a scaly or crusty growth (lesion). It most often appears on the bald scalp, face, ears, lips, backs of the hands and forearms, shoulders, neck, or any other areas of the body frequently exposed to the sun. The predisposing factors include age, sunny climate, history of frequent or intense sun exposure or sunburn, pale skin, red or blond hair, blue or light-colored eyes, and a...
-
Product Insights
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fibroblast growth factor receptor 4 is a protein encoded by the FGFR4 gene. It is required for normal down-regulation of the expression of CYP7A1, the rate-limiting enzyme in bile acid synthesis, in response to FGF19. The Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development market research report provides an in-depth analysis of Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics. The report provides comprehensive information on the Fibroblast Growth Factor...
-
Sector Analysis
Saudi Arabia – Healthcare, Regulatory and Reimbursement Landscape
The Saudi Arabia pharmaceutical market was valued at $10.2 billion in 2020. The market will grow at a CAGR of more than 6% from 2020 to 2026. The Saudi Arabia medical devices market was valued at $4.8 billion in 2021 and is expected to grow at a CAGR of more than 4% from 2021 to 2027. Saudi Arabia is one of the most attractive economies in the Middle East and North Africa (MENA) in terms of healthcare and regulatory reforms,...
-
Consumer Insights
COVID-19 Survey Snapshot: Impact on Consumer Behavior in Europe – Week 4
GlobalData is carrying out weekly consumer surveys in 11 countries between 25th March and 31st May 2020, to track consumer sentiment and shopping behavior during the Coronavirus (COVID19) pandemic. The sample size is 500 respondents per country, per week. The four countries in scope for Europe are Germany, Italy, Sweden, and the UK. Questions are consistent every week, and cover consumer opinions about COVID-19, buying behavior and product choices and impact of the Coronavirus (COVID19) outbreak on consumers' lifestyle and...